Genitourinary syndrome of menopause: hard to communicate, easy to treat
Casopis lekaru ceskych.
2019 Summer ;
158 (3-4) :
101-106.
Language English Country Czech Republic Media print
Document type Journal Article
Persistent link
https://www.medvik.cz/link/pmid31416315
PubMed
31416315
PII: 113318
Knihovny.cz E-resources
- Keywords
- estradiol, estriol, genitourinary syndrome of menopause, ospemifene, prasteron, vaginal application, vulvovaginal atrophy,
- MeSH
- Atrophy MeSH
- Humans MeSH
- Menopause * MeSH
- Vulvar Diseases * diagnosis therapy MeSH
- Syndrome MeSH
- Vagina MeSH
- Vaginal Diseases * diagnosis therapy MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
About 40 % of woman suffer from vulvovaginal atrophy after menopausal transition. It is very important to put question on this problem, because about 70 % of them are not able to start discussion on it. Regarding treatment, vaginal low doses estriol and estradiol are drugs of first choice with high efficacy and safety.
